Want to see XTLB full AI Analyst Report?

XTL Biopharmaceuticals Sponsored ADR (XTLB) Revenue

146 Followers

XTL Biopharmaceuticals Sponsored ADR Revenue

XTL Biopharmaceuticals Sponsored ADR had a revenue of 289.00K in the quarter ending Dec 31, 2024, with 78.40%. This bring the company's revenue in the last twelve months to 451.00K, Decreased 178.40%. In the fiscal year ending Dec 31, 2025, XTL Biopharmaceuticals Sponsored ADR had annual revenue of 0.00 with -100.00% growth.

Revenue (ttm)

451.00K

Revenue Growth

―

P/S Ratio

―

Revenue/Employee

Employees

Market Cap

$10.14M

Revenue Chart

Revenue History

Fiscal End Date	Revenue	Change	Growth
Dec 31, 2025	―	-451.00K	-100.00%
Dec 31, 2024	451.00K	―	+∞%
Dec 31, 2023	―	―	―
Dec 31, 2022	―	―	―
Dec 31, 2021	―	―	―
Dec 31, 2020	―	―	―
Dec 31, 2019	―	―	―
Dec 31, 2018	―	―	―
Dec 31, 2017	―	―	―